Valuation: Medpace Holdings, Inc.

Market Cap 15.52B 13.63B 12.55B 11.69B 22.05B 1,476B 22.5B 151B 58.47B 724B 58.29B 57.03B 2,521B P/E 2026 *
31.9x
P/E 2027 * 29.2x
Enterprise Value 14.36B 12.6B 11.6B 10.81B 20.39B 1,365B 20.8B 140B 54.06B 670B 53.9B 52.73B 2,331B EV / Sales 2026 *
5.17x
EV / Sales 2027 * 4.72x
Free-Float
80.38%
Yield 2026 *
-
Yield 2027 * -
1 day+2.64%
1 week+6.00%
Current month+2.64%
1 month+20.40%
3 months+11.05%
6 months-3.22%
Current year-3.22%
1 week 516
Extreme 516.0001
555
1 month 434.38
Extreme 434.38
555
Current year 373
Extreme 373
628.92
1 year 306.7
Extreme 306.7035
628.92
3 years 227.21
Extreme 227.21
628.92
5 years 126.94
Extreme 126.945
628.92
10 years 21.76
Extreme 21.76
628.92
Manager TitleAgeSince
Chief Executive Officer 69 1992-06-30
Director of Finance/CFO 51 2021-07-31
Chief Tech/Sci/R&D Officer 65 2017-08-31
Director TitleAgeSince
Chairman 69 1992-06-30
Director/Board Member 55 2016-06-30
Director/Board Member 72 2016-06-30
Date Insider Type Main position Quantity % Market Cap.
05-31Other

Executive/Senior Manager

16,197 0.0567%
05-27Fiscal year

Compliance Officer

49,047 0.1717%
05-14Free

Director

1,110 0.0039%
Change 5-day change 1-year change 3-year change Capi.($)
+2.64%+6.00%+69.30%+126.33% 15.52B
+0.07%+4.65%+0.57%+6.16% 48.62B
+0.12%+10.45%+408.29%+600.97% 39.86B
+5.17%+9.47%+24.96%-9.60% 33.91B
+2.02%+4.91%+18.59%+63.06% 32.32B
+0.69%+1.04%+14.23%+30.86% 24.73B
+0.40%+12.51% - - 16.63B
+0.53%+0.67%+13.32%+18.03% 13.63B
+0.77%+10.67%+17.58%-30.04% 13.41B
-0.13%+3.49%+98.27%+93.01% 13.09B
Average +1.21%+6.69%+73.90%+99.86% 25.17B
Weighted average by Cap. +1.30%+6.95%+88.82%+126.56%

Financials

2026 *2027 *
Net sales 2.77B 2.44B 2.24B 2.09B 3.94B 264B 4.02B 26.97B 10.45B 129B 10.42B 10.19B 451B 2.95B 2.59B 2.38B 2.22B 4.19B 280B 4.27B 28.65B 11.1B 138B 11.07B 10.83B 479B
Net income 492M 432M 398M 371M 699M 46.81B 713M 4.79B 1.85B 22.98B 1.85B 1.81B 79.96B 539M 473M 436M 406M 766M 51.27B 781M 5.24B 2.03B 25.16B 2.02B 1.98B 87.58B
Net Debt -1.17B -1.03B -945M -880M -1.66B -111B -1.69B -11.36B -4.4B -54.55B -4.39B -4.29B -190B -1.62B -1.42B -1.31B -1.22B -2.3B -154B -2.34B -15.73B -6.09B -75.5B -6.07B -5.94B -263B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,300
Date Price Change Volume
26-07-01 US$543.57 +2.64% 312,635
26-06-30 US$529.59 -0.96% 335,554
26-06-29 US$534.72 +1.45% 390,789
26-06-26 US$527.07 +1.37% 399,920
26-06-25 US$519.96 +1.40% 400,918
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
543.57USD
Average target price
443.50USD
Spread / Average Target
-18.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock